Paradoxical cytoskeleton and microparticle formation changes in monocytes and polymorphonuclear leukocytes in severe systemic inflammatory response syndrome patients

Journal of Trauma

Volumn 55, Issue 6, 2003, Pages 1125-1132

  Sumi, Yuka Itakura ^a   Ogura, Hiroshi ^a   Tanaka, Hiroshi ^a   Koh, Taichin ^a   Fujita, Kieko ^a   Fujimi, Satoshi ^a   Nakamori, Yasushi ^a   Shimazu, Takeshi ^a   Sugimoto, Hisashi ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

F actin; Microparticle; Monocyte; Polymorphonuclear leukocyte; Systemic inflammatory response syndrome (SIRS)

Indexed keywords

CD64 ANTIGEN; F ACTIN; FORMYLMETHIONYLLEUCYLPHENYLALANINE; HLA DR ANTIGEN; LIPOPOLYSACCHARIDE;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CELL LEVEL; CELL MEMBRANE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSKELETON; DISEASE SEVERITY; FEMALE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LEUKOCYTE ACTIVATION; MALE; MONOCYTE; NEUTROPHIL; OXIDATION; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN CONTENT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ACTINS; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CYTOSKELETON; FEMALE; FLOW CYTOMETRY; HLA-DR ANTIGENS; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKOCYTE COUNT; LIPOPOLYSACCHARIDES; MALE; MICROFILAMENTS; MIDDLE AGED; MONOCYTES; N-FORMYLMETHIONINE LEUCYL-PHENYLALANINE; NEUTROPHILS; OXIDATION-REDUCTION; RECEPTORS, IGG; SEVERITY OF ILLNESS INDEX; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 0347991605     PISSN: 00225282     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TA.0000096663.21402.5C     Document Type: Article

References (32)

1. Kox W, Volk T. Immunomodulatory therapies in sepsis. Intensive Care Med. 2000; 26; S124-S128.
2. Oberholzer A, Oberholzer C. Sepsis syndromes; understanding the role of innate and acquired immunity. Shock. 2001; 16; 83-96.
3. Ogura H, Kawasaki T, Tanaka H, et al. Activated platelets enhance microparticle formation and platelet-leukocyte interaction in severe trauma and sepsis. J Trauma. 2001; 50; 801-809.
4. Fujimi S, Ogura H, Tanaka H, et al. Activated polymorphonuclear leukocytes enhance production of leukocyte microparticles with increased adhesion molecules in patients with sepsis. J Trauma. 2001; 52; 443-448.
5. Satta N, Totti F, Feugeas O, et al. Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol. 1994; 153; 3245-3255.
6. Mersi M, Altieri D. Leukocyte microparticles stimulate endothelial cell cytokine release and tissue factor induction in a JNK1 signaling pathway. J Biol Chem. 1999; 274; 23111-23118.
7. Omoto S, Nomura S, Shouzu A, et al. Detection of monocyte-derived microparticles in patients with Type II diabetes mellitus. Diabetologia. 2002; 45; 550-555.
8. Nomura S, Kanazawa S, Fukuhara S. Effects of efonidipine on platelet and monocyte activation markers in hypertensive patients with and without type 2 diabetes mellitus. J Hum Hypertens. 2002; 16; 539-547.
9. Brom J, Köller M, Schlüter B, et al. Expression of the adhesion molecule CD11b and polymerization of actin by polymorphonuclear granulocytes of patients endangered by sepsis. Burns. 1995; 21; 427-431.
10. Matthew R, Saman A, Gregory J, et al. The actin cytoskeleton; an essential component for enhanced TNF-alpha production by adherent monocytes. Shock. 2002; 17; 109-113.
11. Vindenes H, Bjerknes R. Impaired actin polymerization and depolymerization in neutrophils from patients with thermal injury. Burns. 1997; 23; 131-136.
12. Rosengart M, Arbabi S, Garcia I, et al. Adherence potentiates monocyte lipopolysaccharide-induced tumor necrosis factor-alpha production; a process dependent on Pyk2. Surg Forum. 1999; 50; 275-278.
13. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference. Definition for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med. 1992; 20; 864-874.
14. Goris RJ, Boekhorst PA, Johannes KS, et al. Multiple organ failure. Arch Surg. 1985; 120; 1109-1115.
15. Xie G, Nomura S, Fukuhara S, et al. Annexin V expression and membrane vesiculation during activation of leukemic cell lines. Haemostasis. 1997; 27; 259-268.
16. Mehdi M, Dario C. Endothelial cell activation by leukocyte microparticles. J Immunol. 1998; 161; 4382-4387.
17. Van F, Diesselhoff-den D, Mattie H, et al. Quantitative study on the production and kinetics of mononuclear phagocytes during acute inflammatory reaction. J Exp Med. 1973; 138; 1314-1330.
18. Shinji H, Akagawa K, Yoshida T, et al. Cytochalasin D inhibits lipopolysaccharide-induced tumor necrosis factor production in macrophages. J Leukoc Biol. 1993; 54; 336-342.
19. Muller A, Tulleken J, Zijlstra J, et al. Leukocyte activation in sepsis; correlations with disease state and mortality. Intensive Care Med. 2000; 26; 883-892.
20. Distchkowski M, Kreuzfelder E, Regmann V, et al. HLA-DR expression and soluble HLA-DR levels in septic patients after trauma. Ann Surg. 1999; 229; 246-254.
21. Schinkel C, Sendtner R, Zimmer S, et al. Functional analysis of monocyte subsets in surgical sepsis. J Trauma. 1998; 44; 743-748.
22. Appel S, Wellhausen S, Montgomery R, et al. Experimental and clinical significance of endotoxin-dependent HLA-DR expression on monocytes. J Surg Res. 1989; 47; 39-44.
23. Doecke W, Randow F, Syrbe U, et al. Monocyte deactivation in septic patients; restoration by INF-gamma treatment. Nat Med. 1997; 3; 678-681.
24. Majetschak M, Flach R, Kreuzfelder E, et al. The extent of traumatic damage determines a graded depression of the endotoxin responsiveness of peripheral blood mononuclear cells from patients with blunt injuries. Crit Care Med. 1999; 27; 313-318.
25. Ziegenfuss T, Wanner G, Grass C, et al. Mixed agonistic-antagonistic cytokine response in whole blood from patients undergoing abdominal aortic aneurysm repair. Intensive Care Med. 1999; 25; 279-287.
26. Wolfram W, Ulrich G, Hauke R, et al. Monocyte deactivation in severe human sepsis or following cardiopulmonary bypass. Shock. 2002; 17; 354-360.
27. Ertel W, Kremer J, Kenney J, et al. Down-regulation of proinflammatory cytokine release in whole blood from septic patients. Blood. 1995; 85; 1341-1347.
28. Heagy W, Hansen C, Nieman K, et al. Impaired ex vivo lipopolysaccharide-stimulated whole blood tumor necrosis factor production may identify 'septic' intensive care unit patients. Shock. 2000; 14; 271-277.
29. Marc A, Stuart W, Adrian C, et al. Monocyte anergy in septic shock is associated with predilection to apoptosis and is reversed by granulocyte-macrophage colony stimulating factor ex vivo. J Infect Dis. 1998; 178; 1421-1433.
30. Minou A, Karim A, Pierre M, et al. Long-term-impaired expression of nuclear factor-kappaB and IkappaBalpha in peripheral blood mononuclear cells of trauma patients. J Leukoc Biol. 2001; 70; 30-39.
31. Ogura H, Hashiguchi N, Tanaka H, et al. Long-term enhanced expression of heat shock proteins and decelerated apoptosis in polymorphonuclear leukocytes from major burn patients. J Burn Care Rehabil. 2002; 23; 103-109.
32. Nakamori Y, Koh T, Ogura H, et al. Enhanced expression of intranuclear NF-kappaB in primed polymorphonuclear leukocytes in SIRS patients. J Trauma. 2002; 54; 253-260.